Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Option exercise Director acquired 9,387 shares (option exercise)
  2. 4 Option exercise Director acquired 9,387 shares (option exercise)
  3. 4 Option exercise Director acquired 9,387 shares (option exercise)
  4. 4 Grant or award Director acquired 32,428 shares (grant or award)
  5. 4 Planned sale PRINCIPAL ACCOUNTING OFFICER sold 4,000 shares at an average $22.50 ($90,000)
  6. 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 2,000 shares at $25.00 ($50,000)
  7. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,327 shares at $14.60 ($19,374)
  8. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,498 shares at $14.60 ($51,071)
  9. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 2,708 shares at $14.82 ($40,133)
  10. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,028 shares at $14.82 ($15,235)
  11. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,095 shares at $17.05 ($18,670)
  12. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,171 shares at $17.05 ($54,066)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Director sold 4,919 shares at $18.23 ($89,673)
  17. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 475 shares at $19.96 ($9,481)
  18. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 773 shares at $19.96 ($15,429)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 3 of 35 · 686 filings